Tahillioglu, AkinOzcan, TugceYuksel, GamzeMajroh, NoorjahanKose, SezenOzbaran, Burcu2020-12-012020-12-0120202050-09042050-0904https://doi.org/10.1002/ccr3.3271https://hdl.handle.net/11454/61931Aripiprazole contributes an increase in body mass index and attenuation in anorexia nervosa (AN) symptoms, leading clinical improvements with lower side-effect profile; but it is not enough to cure comorbid depressive symptoms in AN.en10.1002/ccr3.3271info:eu-repo/semantics/openAccessanorexia nervosaaripiprazoleBMIcase seriesdepressionfollow-uptreatmentArticleWOS:0005662803000012-s2.0-85090211910N/AN/A